454 related articles for article (PubMed ID: 27864111)
21. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
[TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae).
Gordien AY; Gray AI; Franzblau SG; Seidel V
J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141
[TBL] [Abstract][Full Text] [Related]
23. Antimycobacterial and cytotoxic activity of selected medicinal plant extracts.
Nguta JM; Appiah-Opong R; Nyarko AK; Yeboah-Manu D; Addo PG; Otchere I; Kissi-Twum A
J Ethnopharmacol; 2016 Apr; 182():10-5. PubMed ID: 26875647
[TBL] [Abstract][Full Text] [Related]
24. Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae).
Fadipe VO; Mongalo NI; Opoku AR; Dikhoba PM; Makhafola TJ
BMC Complement Altern Med; 2017 Jun; 17(1):306. PubMed ID: 28606081
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of biofilm formation in Mycobacterium smegmatis by Parinari curatellifolia leaf extracts.
Bhunu B; Mautsa R; Mukanganyama S
BMC Complement Altern Med; 2017 May; 17(1):285. PubMed ID: 28558683
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of antimicrobial compounds from Terminalia phanerophlebia Engl. & Diels leaf extracts.
Madikizela B; Aderogba MA; Finnie JF; Van Staden J
J Ethnopharmacol; 2014 Oct; 156():228-34. PubMed ID: 25218320
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
Altaf M; Miller CH; Bellows DS; O'Toole R
Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
[TBL] [Abstract][Full Text] [Related]
28. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
29. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.
Bunalema L; Fotso GW; Waako P; Tabuti J; Yeboah SO
BMC Complement Altern Med; 2017 Feb; 17(1):89. PubMed ID: 28148252
[TBL] [Abstract][Full Text] [Related]
30. Survey on medicinal plants traditionally used in Senegal for the treatment of tuberculosis (TB) and assessment of their antimycobacterial activity.
Diop EA; Queiroz EF; Kicka S; Rudaz S; Diop T; Soldati T; Wolfender JL
J Ethnopharmacol; 2018 Apr; 216():71-78. PubMed ID: 29289797
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mycobacterial growth by plumbagin derivatives.
Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of Mycobacterium tuberculosis to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana and isolated compounds.
Lawal TO; Adeniyi BA; Adegoke AO; Franzblau SG; Mahady GB
Pharm Biol; 2012 Jan; 50(1):92-8. PubMed ID: 22129202
[TBL] [Abstract][Full Text] [Related]
33. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
34. Anti-tuberculosis constituents from the stem bark of Micromelum hirsutum.
Ma C; Case RJ; Wang Y; Zhang HJ; Tan GT; Van Hung N; Cuong NM; Franzblau SG; Soejarto DD; Fong HH; Pauli GF
Planta Med; 2005 Mar; 71(3):261-7. PubMed ID: 15770548
[TBL] [Abstract][Full Text] [Related]
35. Anti-mycobacterial triterpenes from the Canadian medicinal plant Alnus incana.
Li H; Webster D; Johnson JA; Gray CA
J Ethnopharmacol; 2015 May; 165():148-51. PubMed ID: 25725435
[TBL] [Abstract][Full Text] [Related]
36. Nonquaternary poly(diallylammonium) polymers with different amine structure and their biocidal effect on Mycobacterium tuberculosis and Mycobacterium smegmatis.
Timofeeva LM; Kleshcheva NA; Shleeva MO; Filatova MP; Simonova YA; Ermakov YA; Kaprelyants AS
Appl Microbiol Biotechnol; 2015 Mar; 99(6):2557-71. PubMed ID: 25557627
[TBL] [Abstract][Full Text] [Related]
37. Antitubercular activity of the semi-polar extractives of Uvaria rufa.
Macabeo AP; Tudla FA; Krohn K; Franzblau SG
Asian Pac J Trop Med; 2012 Oct; 5(10):777-80. PubMed ID: 23043915
[TBL] [Abstract][Full Text] [Related]
38. The Canadian medicinal plant Heracleum maximum contains antimycobacterial diynes and furanocoumarins.
O'Neill T; Johnson JA; Webster D; Gray CA
J Ethnopharmacol; 2013 May; 147(1):232-7. PubMed ID: 23501157
[TBL] [Abstract][Full Text] [Related]
39. Medicinal plants from open-air markets in the State of Rio de Janeiro, Brazil as a potential source of new antimycobacterial agents.
Leitão F; Leitão SG; de Almeida MZ; Cantos J; Coelho T; da Silva PE
J Ethnopharmacol; 2013 Sep; 149(2):513-21. PubMed ID: 23871806
[TBL] [Abstract][Full Text] [Related]
40. Anti-mycobacterial activity of polyketides from Penicillium sp. endophyte isolated from Garcinia nobilis against Mycobacteriumsmegmatis.
Jouda JB; Mawabo IK; Notedji A; Mbazoa CD; Nkenfou J; Wandji J; Nkenfou CN
Int J Mycobacteriol; 2016 Jun; 5(2):192-6. PubMed ID: 27242231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
